製品の概要

製品の詳細

  • 由来Synthetic
  • アミノ酸配列
    • 生物種Human
    • 配列LKACYYQIQREKLN
    • 領域1644 to 1657

関連製品

特性

Our Abpromise guarantee covers the use of ab22998 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • アプリケーション

    Blocking - Blocking peptide for Anti-Als2 antibody (ab4155)

  • 製品の状態Liquid
  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

関連情報

  • 別名
    • ALS 2
    • ALS2
    • ALS2_HUMAN
    • ALS2CR6
    • Alsin
    • ALSJ
    • Amyotrophic lateral sclerosis 2 (juvenile)
    • Amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 6
    • Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein
    • Amyotrophic lateral sclerosis 2 protein
    • Amyotrophic lateral sclerosis protein 2
    • FLJ31851
    • IAHSP
    • KIAA1563
    • MGC87187
    • PLSJ
    see all
  • 機能May act as a GTPase regulator. Controls survival and growth of spinal motoneurons.
  • 関連疾患Defects in ALS2 are the cause of amyotrophic lateral sclerosis type 2 (ALS2) [MIM:205100]. ALS2 is a familial form of amyotrophic lateral sclerosis, a neurodegenerative disorder affecting upper and lower motor neurons and resulting in fatal paralysis. Sensory abnormalities are absent. Death usually occurs within 2 to 5 years. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of cases leading to familial forms.
    Defects in ALS2 are the cause of juvenile primary lateral sclerosis (JPLS) [MIM:606353]. JPLS is a neurodegenerative disorder which is closely related to but clinically distinct from amyotrophic lateral sclerosis. It is a progressive paralytic disorder which results from dysfunction of the upper motor neurons of the motor cortex while the lower neurons are unaffected.
    Defects in ALS2 are the cause of infantile-onset ascending spastic paralysis (IAHSP) [MIM:607225]. IAHSP is characterized by progressive spasticity and weakness of limbs.
  • 配列類似性Contains 1 DH (DBL-homology) domain.
    Contains 8 MORN repeats.
    Contains 1 PH domain.
    Contains 5 RCC1 repeats.
    Contains 1 VPS9 domain.
  • 翻訳後修飾Phosphorylated upon DNA damage, probably by ATM or ATR.
  • Information by UniProt

Human Als2 peptide (ab22998) 使用論文

ab22998 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab22998.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"